naphthalenesulfonamide has been researched along with ml 7 in 1 studies
| Studies (naphthalenesulfonamide) | Trials (naphthalenesulfonamide) | Recent Studies (post-2010) (naphthalenesulfonamide) | Studies (ml 7) | Trials (ml 7) | Recent Studies (post-2010) (ml 7) |
|---|---|---|---|---|---|
| 16 | 0 | 4 | 258 | 0 | 88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badwey, JA; Curnutte, JT; Ding, J; Erickson, RW; Heyworth, PG | 1 |
1 other study(ies) available for naphthalenesulfonamide and ml 7
| Article | Year |
|---|---|
Naphthalenesulphonamides block neutrophil superoxide production by intact cells and in a cell-free system: is myosin light chain kinase responsible for these effects?
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Azepines; Cell-Free System; Enzyme Inhibitors; Guinea Pigs; Humans; Isoquinolines; Myosin-Light-Chain Kinase; Naphthalenes; Neutrophils; Octoxynol; Piperazines; Sulfonamides; Superoxides; Tetradecanoylphorbol Acetate | 1995 |